Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 29, 2024Frontiers in ImmunologyOpen Access

Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAlla BulashevskaZNZsófia NacsaFLFranziska Lang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bulashevska et al. (2024) studied this question.

synapsesocial.com/papers/68e67cc7b6db643587606dcfhttps://doi.org/10.3389/fimmu.2024.1394003
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy2023 · 80 citations
  2. 2AI-driven neoantigen identification: a comprehensive review from somatic variant calling to T cell recognition2026
  3. 3Artificial intelligence for translational personalized neoantigen cancer vaccine development2026
  4. 4Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives2026
  5. 5Advances in Bioinformatics Techniques to Predict Neoantigen: Exploring Tumor Immune Microenvironment and Transforming Data into Therapeutic Insights2024